Michael J. LaBarre

CIK 1507174 · SVP, CHIEF TECHNICAL OFFICER · last filed 2025-02-27

Michael J. LaBarre is a SVP, CHIEF TECHNICAL OFFICER who has filed 65 SEC Form 4 insider transactions across 1 company since 2011. The most recent filing shows the insider sold $1.3M of HTI on Feb 27, 2025. Across all open-market trades the lifetime net is −$25.2M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

65

Lifetime Open-Market Net

-$25.16M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
HALOZYME THERAPEUTICS, INC. (HTI) Delisted SVP, CHIEF TECHNICAL OFFICER 173,856 -$25.16M 65 2025-02-27

Recent Filings

65 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-02-27 HALOZYME THERAPEUTICS, INC. (HTI) Delisted Sell (S) −21,697 -$1.26M EDGAR
2025-02-24 HALOZYME THERAPEUTICS, INC. (HTI) Delisted Mixed +2,337 -$139.2K EDGAR
2025-02-21 HALOZYME THERAPEUTICS, INC. (HTI) Delisted Grant (A) $0 EDGAR
2025-02-18 HALOZYME THERAPEUTICS, INC. (HTI) Delisted Mixed +19,360 -$891.4K EDGAR
2025-02-14 HALOZYME THERAPEUTICS, INC. (HTI) Delisted Grant (A) $0 EDGAR
2024-10-16 HALOZYME THERAPEUTICS, INC. (HTI) Delisted Mixed -$688.8K EDGAR
2024-09-18 HALOZYME THERAPEUTICS, INC. (HTI) Delisted Mixed -$916.1K EDGAR
2024-08-27 HALOZYME THERAPEUTICS, INC. (HTI) Delisted Exer (M) +5,580 $102.7K EDGAR
2024-08-21 HALOZYME THERAPEUTICS, INC. (HTI) Delisted Mixed -$895.0K EDGAR
2024-07-24 HALOZYME THERAPEUTICS, INC. (HTI) Delisted Mixed -$867.1K EDGAR
Showing 110 of 65
Page 1 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.